ATE478942T1 - Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen - Google Patents

Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen

Info

Publication number
ATE478942T1
ATE478942T1 AT04777586T AT04777586T ATE478942T1 AT E478942 T1 ATE478942 T1 AT E478942T1 AT 04777586 T AT04777586 T AT 04777586T AT 04777586 T AT04777586 T AT 04777586T AT E478942 T1 ATE478942 T1 AT E478942T1
Authority
AT
Austria
Prior art keywords
disorders
treatment
patient
methods
kidney diseases
Prior art date
Application number
AT04777586T
Other languages
English (en)
Inventor
Marc Hedrick
John Fraser
Eric Daniels
Original Assignee
Cytori Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytori Therapeutics Inc filed Critical Cytori Therapeutics Inc
Application granted granted Critical
Publication of ATE478942T1 publication Critical patent/ATE478942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04777586T 2004-07-01 2004-07-01 Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen ATE478942T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/021549 WO2006014162A2 (en) 2004-07-01 2004-07-01 Methods of using regenerative cells in the treatment of renal diseases and disorders

Publications (1)

Publication Number Publication Date
ATE478942T1 true ATE478942T1 (de) 2010-09-15

Family

ID=35787532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777586T ATE478942T1 (de) 2004-07-01 2004-07-01 Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen

Country Status (6)

Country Link
EP (1) EP1778834B9 (de)
AT (1) ATE478942T1 (de)
DE (1) DE602004028876D1 (de)
DK (1) DK1778834T5 (de)
ES (1) ES2351341T3 (de)
WO (1) WO2006014162A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074316A2 (de) * 2006-12-21 2008-06-26 B. Braun Medizintechnologie Gmbh Verfahren zur steuerung einer vorrichtung zur extrakorporalen blutbehandlung und vorrichtung zur extrakorporalen blutbehandlung
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
CN105013032B (zh) 2014-03-31 2018-06-22 甘布罗伦迪亚股份公司 体外血液处理系统及用于该系统的方法
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
CN109564231B (zh) 2016-06-08 2023-01-06 加利福尼亚大学董事会 用于处理组织和细胞的方法和装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
CN100516200C (zh) * 2001-11-09 2009-07-22 阿特塞尔科学公司 用于角膜和眶内缺损修复的脂肪组织来源的基质细胞及其应用
KR100930139B1 (ko) * 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
WO2005012480A2 (en) * 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue

Also Published As

Publication number Publication date
EP1778834B1 (de) 2010-08-25
DK1778834T3 (da) 2010-11-29
ES2351341T9 (es) 2012-02-14
DK1778834T5 (da) 2012-01-09
ES2351341T3 (es) 2011-02-03
EP1778834A2 (de) 2007-05-02
WO2006014162A3 (en) 2006-03-23
DE602004028876D1 (de) 2010-10-07
WO2006014162A2 (en) 2006-02-09
EP1778834B9 (de) 2011-11-09
EP1778834A4 (de) 2007-09-05

Similar Documents

Publication Publication Date Title
ATE524070T1 (de) Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
ATE500319T1 (de) Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
AU2009100401A4 (en) Method of extracting and activating adipose-derived stem cells
DE602004031782D1 (de) Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
ATE432693T1 (de) Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
EP2305276A3 (de) Zellen aus Lipoaspirat und ihre Verwendung zur Therapie
MX2009012197A (es) Metodos para tratamiento de ulceras en la piel.
MX2015016527A (es) Polimeros enlazados al proton para administracion oral.
EA201001749A1 (ru) Способ лечения недифференцированного артрита
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
DE60320770D1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
ATE478942T1 (de) Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen
WO2008027238A3 (en) Induction of immunosuppression by inhibition of atm
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen
ATE526984T1 (de) Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen
MX2011011114A (es) Materiales y metodos para utilizar celulas madre de tejido adiposo para tratar una lesion y enfermedad pulmonar.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties